The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prediction of lung cancer using volatile biomarkers in breath1
Abstract
BACKGROUND: Normal metabolism generates several volatile organic compounds (VOCs) that are excreted in the breath (e.g. alkanes). In patients with lung cancer, induction of high-risk cytochrome p450 genotypes may accelerate catabolism of these VOCs, so that their altered abundance in breath may provide biomarkers of lung cancer. METHODS: VOCs in 1.0 L alveolar breath were analyzed in 193 subjects with primary lung cancer and 211 controls with a negative chest CT. Subjects were randomly assigned to a training set or to a prediction set in a 2:1 split. A fuzzy logic model of breath biomarkers of lung cancer was constructed in the training set and then tested in subjects in the prediction set by generating their typicality scores for lung cancer. RESULTS: Mean typicality scores employing a 16 VOC model were significantly higher in lung cancer patients than in the control group (p<0.0001 in all TNM stages). The model predicted primary lung cancer with 84.6% sensitivity, 80.0% specificity, and 0.88 area under curve (AUC) of the receiver operating characteristic (ROC) curve. Predictive accuracy was similar in TNM stages 1 through 4, and was not affected by current or former tobacco smoking. The predictive model achieved near-maximal performance with six breath VOCs, and was progressively degraded by random classifiers. Predictions with fuzzy logic were consistently superior to multilinear analysis. If applied to a population with 2% prevalence of lung cancer, a screening breath test would have a negative predictive value of 0.985 and a positive predictive value of 0.163 (true positive rate =0.277, false positive rate =0.029). CONCLUSIONS: A two-minute breath test predicted lung cancer with accuracy comparable to screening CT of chest. The accuracy of the test was not affected by TNM stage of disease or tobacco smoking. Alterations in breath VOCs in lung cancer were consistent with a non-linear pathophysiologic process, such as an off-on switch controlling high-risk cytochrome p450 activity. Further research is needed to determine if detection of lung cancer with this test will reduce mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Revisions in the International System for Staging Lung Cancer
Mountain, C. F. (1997) · Chest · doi:10.1378/chest.111.6.1710 · Cited by 4,565
Early Lung Cancer Action Project: overall design and findings from baseline screening
Henschke, C. I., McCauley, D. I., Yankelevitz, D. F., Naidich, D. P., McGuinness, G., Miettinen, O. S., Libby, D. M., Pasmantier, M. W., Koizumi, J., Altorki, N. K., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)06093-6 · Cited by 2,508
Self-citationQuantitative Analysis of Urine Vapor and Breath by Gas-Liquid Partition Chromatography
Pauling, L., Robinson, A. B., Teranishi, R., & Cary, P. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.10.2374 · Cited by 1,025
Prediction of cancer outcome with microarrays: a multiple random validation strategy
Michiels, S., Koscielny, S., & Hill, C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17866-0 · Cited by 1,025
Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study
Phillips, M., Gleeson, K., Hughes, J. M. B., Greenberg, J., Cataneo, R. N., Baker, L., & McVay, W. P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07552-7 · Cited by 918
Self-citationDrug Interactions with Tobacco Smoking: An Update
Zevin, S., & Benowitz, N. L. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00004 · Cited by 692
Lung Cancer Screening with CT: Mayo Clinic Experience
Swensen, S. J., Jett, J. R., Hartman, T. E., Midthun, D. E., Sloan, J. A., Sykes, A.-M., Aughenbaugh, G. L., & Clemens, M. A. (2003) · Radiology · doi:10.1148/radiol.2263020036 · Cited by 665
Detection of Lung Cancer With Volatile Markers in the Breatha
Phillips, M., Cataneo, R. N., Cummin, A. R. C., Gagliardi, A. J., Gleeson, K., Greenberg, J., Maxfield, R. A., & Rom, W. N. (2003) · Chest · doi:10.1378/chest.123.6.2115 · Cited by 567
Self-citationSone, S., Li, F., Yang, Z.-G., Honda, T., Maruyama, Y., Takashima, S., Hasegawa, M., Kawakami, S., Kubo, K., Haniuda, M., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1531 · Cited by 495
The potential of the hydrocarbon breath test as a measure of lipid peroxidation
Frank Kneepkens, C. M., Lepage, G., & Roy, C. C. (1994) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)90110-4 · Cited by 369
Cited by
Electronic Nose: Current Status and Future Trends
Röck, F., Barsan, N., & Weimar, U. (2008) · Chemical Reviews · doi:10.1021/cr068121q · Cited by 1,437
A review of the volatiles from the healthy human body
de Lacy Costello, B., Amann, A., Al-Kateb, H., Flynn, C., Filipiak, W., Khalid, T., Osborne, D., & Ratcliffe, N. M. (2014) · Journal of Breath Research · doi:10.1088/1752-7155/8/1/014001 · Cited by 1,042
Volatile Organic Compounds of Lung Cancer and Possible Biochemical Pathways
Hakim, M., Broza, Y. Y., Barash, O., Peled, N., Phillips, M., Amann, A., & Haick, H. (2012) · Chemical Reviews · doi:10.1021/cr300174a · Cited by 953
Self-citationAmann, A., Costello, B. D. L., Miekisch, W., Schubert, J., Buszewski, B., Pleil, J., Ratcliffe, N., & Risby, T. (2014) · Journal of Breath Research · doi:10.1088/1752-7155/8/3/034001 · Cited by 804
Metabolomics-based methods for early disease diagnostics
Gowda, G. N., Zhang, S., Gu, H., Asiago, V., Shanaiah, N., & Raftery, D. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.5.617 · Cited by 692
Assessment, origin, and implementation of breath volatile cancer markers
Haick, H., Broza, Y. Y., Mochalski, P., Ruzsanyi, V., & Amann, A. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60329f · Cited by 644
Noninvasive detection of lung cancer by analysis of exhaled breath
Bajtarevic, A., Ager, C., Pienz, M., Klieber, M., Schwarz, K., Ligor, M., Ligor, T., Filipiak, W., Denz, H., Fiegl, M., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-348 · Cited by 597
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD
Dragonieri, S., Annema, J. T., Schot, R., van der Schee, M. P. C., Spanevello, A., Carratú, P., Resta, O., Rabe, K. F., & Sterk, P. J. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2008.08.008 · Cited by 407
The versatile use of exhaled volatile organic compounds in human health and disease
Boots, A. W., van Berkel, J. J. B. N., Dallinga, J. W., Smolinska, A., Wouters, E. F., & van Schooten, F. J. (2012) · Journal of Breath Research · doi:10.1088/1752-7155/6/2/027108 · Cited by 352
Poli, D., Goldoni, M., Corradi, M., Acampa, O., Carbognani, P., Internullo, E., Casalini, A., & Mutti, A. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.01.022 · Cited by 301
VOC breath biomarkers in lung cancer
Saalberg, Y., & Wolff, M. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.05.013 · Cited by 293
Isoprene and acetone concentration profiles during exercise on an ergometer
King, J., Kupferthaler, A., Unterkofler, K., Koc, H., Teschl, S., Teschl, G., Miekisch, W., Schubert, J., Hinterhuber, H., & Amann, A. (2009) · Journal of Breath Research · doi:10.1088/1752-7155/3/2/027006 · Cited by 278
Exhaled biomarkers in lung cancer
Horváth, I., Lázár, Z., Gyulai, N., Kollai, M., & Losonczy, G. (2009) · European Respiratory Journal · doi:10.1183/09031936.00142508 · Cited by 268
Ligor, M., Ligor, T., Bajtarevic, A., Ager, C., Pienz, M., Klieber, M., Denz, H., Fiegl, M., Hilbe, W., Weiss, W., et al. (2009) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2009.133 · Cited by 262
Tangerman, A. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.05.026 · Cited by 257
Volatile biomarkers in the breath of women with breast cancer
Phillips, M., Cataneo, R. N., Saunders, C., Hope, P., Schmitt, P., & Wai, J. (2010) · Journal of Breath Research · doi:10.1088/1752-7155/4/2/026003 · Cited by 253
Self-citationClinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review
van de Kant, K. D., van der Sande, L. J., Jöbsis, Q., van Schayck, O. C., & Dompeling, E. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-117 · Cited by 252
Binson, V. A., & Subramoniam, M. (2022) · Journal of Biomimetics, Biomaterials and Biomedical Engineering · doi:10.4028/p-dab04j · Cited by 14
Metadata
- Authors
- Phillips, M., Altorki, N., Austin, J. H. M., Cameron, R. B., Cataneo, R. N., Greenberg, J., Kloss, R., Maxfield, R. A., Munawar, M. I., Pass, H. I., Rashid, A., Rom, W. N., & Schmitt, P.
- Venue
- Cancer Biomarkers
- Publisher
- SAGE Publications
- Published
- 2007-04-25
- Volume
- 3
- Issue
- 2
- Pages
- 95-109
- ISSN
- 1574-0153 (ISSN-L)
- 1875-8592
- OpenAlex
- W44319099
- Cited by
- 323
- References
- 28
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.